You are Here : Aurobindo under CBI scanner: Is it still a buy?

Tuesday, 10:52

Surajit Pal, pharma analyst at Elara Capital feels that investors can enter the stock around Rs 100 given its fundamentals. I believe the current price roughly around Rs 100 will be the right price to enter considering the prospect in the company for this year and next year in immediate terms, he told CNBC-TV18.
NOV 24, 2017
12:22 AM

cnbc tv18 shows

All Shows

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Follow us on
Available On